Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ZOLEDRONIC ACID Cause Hormone-refractory prostate cancer? 22 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hormone-refractory prostate cancer have been filed in association with ZOLEDRONIC ACID (Zoledronic acid). This represents 0.1% of all adverse event reports for ZOLEDRONIC ACID.

22
Reports of Hormone-refractory prostate cancer with ZOLEDRONIC ACID
0.1%
of all ZOLEDRONIC ACID reports
6
Deaths
2
Hospitalizations

How Dangerous Is Hormone-refractory prostate cancer From ZOLEDRONIC ACID?

Of the 22 reports, 6 (27.3%) resulted in death, 2 (9.1%) required hospitalization.

Is Hormone-refractory prostate cancer Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZOLEDRONIC ACID. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does ZOLEDRONIC ACID Cause?

Osteonecrosis of jaw (5,500) Death (3,053) Pain (2,925) Arthralgia (2,541) Pyrexia (2,455) Fatigue (2,219) Nausea (1,962) Malaise (1,834) Headache (1,739) Asthenia (1,582)

What Other Drugs Cause Hormone-refractory prostate cancer?

RADIUM RA-223 DICHLORIDE (441) LEUPROLIDE (180) DOCETAXEL (123) ENZALUTAMIDE (120) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110) DAROLUTAMIDE (104) ABIRATERONE (83) PREDNISONE (58) CABAZITAXEL (57) BICALUTAMIDE (50)

Which ZOLEDRONIC ACID Alternatives Have Lower Hormone-refractory prostate cancer Risk?

ZOLEDRONIC ACID vs ZOLMITRIPTAN ZOLEDRONIC ACID vs ZOLOFT ZOLEDRONIC ACID vs ZOLPIDEM ZOLEDRONIC ACID vs ZOLPIDEM\ZOLPIDEM ZOLEDRONIC ACID vs ZOMETA

Related Pages

ZOLEDRONIC ACID Full Profile All Hormone-refractory prostate cancer Reports All Drugs Causing Hormone-refractory prostate cancer ZOLEDRONIC ACID Demographics